S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The perfect AI stock under $10 (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The perfect AI stock under $10 (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The perfect AI stock under $10 (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
AI powerhouse NVIDIA will hit $1000 soon
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The perfect AI stock under $10 (Ad)
Roku stock and the mother of all entry opportunities
Rivian shares gets discounted; shares can move lower 
The perfect AI stock under $10 (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Emergent BioSolutions (EBS) Short Interest Ratio & Short Volume

$2.81
+0.10 (+3.69%)
(As of 02/22/2024 ET)

Emergent BioSolutions Short Interest Data

Current Short Volume
10,440,000 shares
Previous Short Volume
11,820,000 shares
Change Vs. Previous Month
-11.68%
Dollar Volume Sold Short
$17.43 million
Short Interest Ratio / Days to Cover
7.8
Last Record Date
January 31, 2024
Outstanding Shares
51,880,000 shares
Float Size
49,750,000 shares
Short Percent of Float
20.98%
Today's Trading Volume
8,430,390 shares
Average Trading Volume
3,585,099 shares
Today's Volume Vs. Average
235%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Emergent BioSolutions ?

Sign up to receive the latest short interest report for Emergent BioSolutions and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EBS Short Interest Over Time

EBS Days to Cover Over Time

EBS Percentage of Float Shorted Over Time


Emergent BioSolutions Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202410,440,000 shares $17.43 million -11.7%21.0%7.8 $1.67
1/15/202411,820,000 shares $24.23 million +1.3%23.8%8.6 $2.05
12/31/202311,670,000 shares $28.01 million +3.0%23.5%8.4 $2.40
12/15/202311,330,000 shares $26.85 million +0.8%22.8%7.8 $2.37
11/30/202311,240,000 shares $24.05 million +4.3%22.6%6.6 $2.14
11/15/202310,780,000 shares $23.82 million -1.4%21.7%5.1 $2.21
10/31/202310,930,000 shares $22.84 million +21.9%22.0%4.7 $2.09
10/15/20238,970,000 shares $22.60 million +14.1%18.1%3.7 $2.52
9/30/20237,860,000 shares $26.72 million -16.9%15.8%3.3 $3.40
9/15/20239,460,000 shares $37.27 million +12.8%19.0%4 $3.94
8/31/20238,390,000 shares $39.35 million -9.3%16.8%3.9 $4.69
8/15/20239,250,000 shares $48.01 million +5.4%18.6%5.6 $5.19
7/31/20238,780,000 shares $60.36 million +5.0%18.1%5.8 $6.88
7/15/20238,360,000 shares $60.28 million +8.3%17.2%6.2 $7.21
6/30/20237,720,000 shares $56.66 million +9.8%15.9%5.3 $7.34
6/15/20237,030,000 shares $56.91 million +3.7%16.2%3.9 $8.10
5/31/20236,780,000 shares $57.83 million +6.8%15.5%3.9 $8.53
5/15/20236,350,000 shares $58.99 million -4.5%14.4%3.4 $9.29
4/30/20236,650,000 shares $58.72 million -7.5%15.1%3.7 $8.83
4/15/20237,190,000 shares $85.20 million -5.4%17.7%4.2 $11.85
3/31/20237,600,000 shares $78.74 million +22.4%18.7%4.6 $10.36
3/15/20236,210,000 shares $59.93 million +11.7%15.3%5.5 $9.65
2/28/20235,560,000 shares $68.83 million -1.1%13.7%5.1 $12.38
2/15/20235,620,000 shares $83.85 million No Change13.9%5.6 $14.92
1/31/20235,620,000 shares $74.13 million +4.9%13.9%5.7 $13.19
1/15/20235,360,000 shares $71.98 million -3.8%13.2%5.4 $13.43
12/30/20225,570,000 shares $65.78 million +63.3%13.7%5.8 $11.81
12/15/20223,410,000 shares $37.99 million +45.7%8.4%3.7 $11.14
11/30/20222,340,000 shares $28.78 million -9.0%5.7%2.9 $12.30
11/15/20222,570,000 shares $34.21 million +19.0%6.3%3.4 $13.31
10/31/20222,160,000 shares $45.06 million +6.4%5.3%3.4 $20.86
10/15/20222,030,000 shares $39.44 million -9.4%5.0%3.1 $19.43
9/30/20222,240,000 shares $47.02 million +9.3%5.5%3.4 $20.99
9/15/20222,050,000 shares $47.27 million +5.1%5.0%3.3 $23.06
8/31/20221,950,000 shares $46.84 million -34.8%4.8%3.1 $24.02
8/15/20222,990,000 shares $91.20 million -15.3%7.3%4.2 $30.50
7/31/20223,530,000 shares $122.28 million +2.6%8.6%4.7 $34.64
7/15/20223,440,000 shares $105.02 million +6.2%8.1%4.6 $30.53
6/30/20223,240,000 shares $100.57 million -3.6%7.6%4.4 $31.04
6/15/20223,360,000 shares $95.42 million -10.2%7.9%4.5 $28.40













EBS Short Interest - Frequently Asked Questions

What is Emergent BioSolutions' current short interest?

Short interest is the volume of Emergent BioSolutions shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 10,440,000 shares of EBS short. 20.98% of Emergent BioSolutions' shares are currently sold short. Learn More on Emergent BioSolutions' current short interest.

What is a good short interest ratio for Emergent BioSolutions?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EBS shares currently have a short interest ratio of 8.0. Learn More on Emergent BioSolutions's short interest ratio.

Which institutional investors are shorting Emergent BioSolutions?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Emergent BioSolutions: Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Emergent BioSolutions?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.98% of Emergent BioSolutions' floating shares are currently sold short.

Is Emergent BioSolutions' short interest increasing or decreasing?

Emergent BioSolutions saw a drop in short interest during the month of January. As of January 31st, there was short interest totaling 10,440,000 shares, a drop of 11.7% from the previous total of 11,820,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Emergent BioSolutions' float size?

Emergent BioSolutions currently has issued a total of 51,880,000 shares. Some of Emergent BioSolutions' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Emergent BioSolutions currently has a public float of 49,750,000 shares.

How does Emergent BioSolutions' short interest compare to its competitors?

20.98% of Emergent BioSolutions' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Emergent BioSolutions: Bolt Biotherapeutics, Inc. (6.77%), Regulus Therapeutics Inc. (0.67%), Molecular Templates, Inc. (1.43%), Rigel Pharmaceuticals, Inc. (1.96%), Merrimack Pharmaceuticals, Inc. (5.33%), Vanda Pharmaceuticals Inc. (3.98%), XOMA Co. (2.79%), Leap Therapeutics, Inc. (2.73%), Assertio Holdings, Inc. (9.97%), Eagle Pharmaceuticals, Inc. (7.01%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Emergent BioSolutions stock?

Short selling EBS is an investing strategy that aims to generate trading profit from Emergent BioSolutions as its price is falling. EBS shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Emergent BioSolutions?

A short squeeze for Emergent BioSolutions occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EBS, which in turn drives the price of the stock up even further.

How often is Emergent BioSolutions' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EBS, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:EBS) was last updated on 2/23/2024 by MarketBeat.com Staff